Bringing the fundamentals into focus…
Back to Supernus Pharmaceuticals, Inc.
How Supernus Pharmaceuticals, Inc. stacks up
SUPN · against 1,216 other Healthcare companies
Growth
50/ 100
Below the middle of the pack.
Ranked #603 of 1,217 · scores higher than 50% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 50–59, including SUPN · Click a bar to see the companies
Why growth scores 50?
Weighted metrics compared with all Healthcare companies.A mix: stronger revenue growth and 3-year revenue growth, but weaker earnings per share growth than most Healthcare peers.
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 61% of peers. 3-year revenue growth: 9.4% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 83% of peers. Revenue growth: 24.9% vs peer median 6.1%
Metric by metric
Position: dot = SUPN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SUPN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 24.9% | 6.1% | 83% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 9.4% | 5.8% | 61% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around SUPN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 603 | 133.4B BRL (≈$24.0B) | 50 | 49 | |
| 603 | 21.1B ZAR (≈$1.2B) | 50 | 60 | |
| 603 | 253M USD | 50 | 15 | |
| 603 | 3.0B USD | 50 | 39 | |
| 603 | 1.6B USD | 50 | 48 | |
| 616 | 11.6B HKD (≈$1.5B) | 49 | 36 | |
| 616 | 406.2B KRW (≈$292M) | 49 | 51 | |
| 616 | 6.8B HKD (≈$867M) | 49 | 56 | |
| 616 | 78.6B JPY (≈$535M) | 49 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score